<VariationArchive VariationID="2129979" VariationName="NM_000278.5(PAX2):c.242del (p.Gly81fs)" VariationType="Deletion" Accession="VCV002129979" Version="2" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-02-29" DateCreated="2023-02-08" MostRecentSubmission="2024-02-28">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="2189256" VariationID="2129979">
      <GeneList>
        <Gene Symbol="PAX2" FullName="paired box 2" GeneID="5076" HGNC_ID="HGNC:8616" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>10q24.31</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="10" Accession="NC_000010.11" start="100735396" stop="100829944" display_start="100735396" display_stop="100829944" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="10" Accession="NC_000010.10" start="102505467" stop="102589697" display_start="102505467" display_stop="102589697" Strand="+" />
          </Location>
          <OMIM>167409</OMIM>
          <Haploinsufficiency last_evaluated="2020-02-26" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=PAX2">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2020-02-26" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=PAX2">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_000278.5(PAX2):c.242del (p.Gly81fs)</Name>
      <CanonicalSPDI>NC_000010.11:100750720:GGG:GG</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>10q24.31</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="10" Accession="NC_000010.11" start="100750721" stop="100750721" display_start="100750721" display_stop="100750721" variantLength="1" positionVCF="100750720" referenceAlleleVCF="CG" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="10" Accession="NC_000010.10" start="102510478" stop="102510478" display_start="102510478" display_stop="102510478" variantLength="1" positionVCF="102510477" referenceAlleleVCF="CG" alternateAlleleVCF="C" />
      </Location>
      <ProteinChange>G112fs</ProteinChange>
      <ProteinChange>G81fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000010.10" sequenceAccession="NC_000010" sequenceVersion="10" change="g.102510480del" Assembly="GRCh37">
            <Expression>NC_000010.10:g.102510480del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000010.11" sequenceAccession="NC_000010" sequenceVersion="11" change="g.100750723del" Assembly="GRCh38">
            <Expression>NC_000010.11:g.100750723del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008680.2" sequenceAccession="NG_008680" sequenceVersion="2" change="g.20015del">
            <Expression>NG_008680.2:g.20015del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_120442.1" sequenceAccession="NG_120442" sequenceVersion="1" change="g.620del">
            <Expression>NG_120442.1:g.620del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000278.5" sequenceAccession="NM_000278" sequenceVersion="5" change="c.242del" MANESelect="true">
            <Expression>NM_000278.5:c.242del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000269.3" sequenceAccession="NP_000269" sequenceVersion="3" change="p.Gly81fs">
            <Expression>NP_000269.3:p.Gly81fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001304569.2" sequenceAccession="NM_001304569" sequenceVersion="2" change="c.335del">
            <Expression>NM_001304569.2:c.335del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001291498.1" sequenceAccession="NP_001291498" sequenceVersion="1" change="p.Gly112fs">
            <Expression>NP_001291498.1:p.Gly112fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_003987.5" sequenceAccession="NM_003987" sequenceVersion="5" change="c.242del">
            <Expression>NM_003987.5:c.242del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_003978.3" sequenceAccession="NP_003978" sequenceVersion="3" change="p.Gly81fs">
            <Expression>NP_003978.3:p.Gly81fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_003988.5" sequenceAccession="NM_003988" sequenceVersion="5" change="c.242del">
            <Expression>NM_003988.5:c.242del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_003979.2" sequenceAccession="NP_003979" sequenceVersion="2" change="p.Gly81fs">
            <Expression>NP_003979.2:p.Gly81fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_003989.5" sequenceAccession="NM_003989" sequenceVersion="5" change="c.242del">
            <Expression>NM_003989.5:c.242del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_003980.3" sequenceAccession="NP_003980" sequenceVersion="3" change="p.Gly81fs">
            <Expression>NP_003980.3:p.Gly81fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_003990.5" sequenceAccession="NM_003990" sequenceVersion="5" change="c.242del">
            <Expression>NM_003990.5:c.242del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_003981.3" sequenceAccession="NP_003981" sequenceVersion="3" change="p.Gly81fs">
            <Expression>NP_003981.3:p.Gly81fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000278.5(PAX2):c.242del (p.Gly81fs) AND multiple conditions" Accession="RCV003044305" Version="2">
        <ClassifiedConditionList TraitSetID="26560">
          <ClassifiedCondition DB="MedGen" ID="C4014925">Focal segmental glomerulosclerosis 7</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C1852759">Renal coloboma syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-04-24" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-04-24" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2023-02-08" MostRecentSubmission="2024-02-28">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">11461952</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">24676634</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="26560" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="3472" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Renal coloboma syndrome</ElementValue>
                <XRef ID="Papillorenal+syndrome/5572" DB="Genetic Alliance" />
                <XRef ID="MONDO:0007352" DB="MONDO" />
                <XRef ID="446449009" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Optic nerve coloboma with renal disease</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Optic coloboma, vesicoureteral reflux, and renal anomalies</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Coloboma of optic nerve with renal disease</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">PAPILLORENAL SYNDROME WITH MILD OCULAR ABNORMALITIES</ElementValue>
                <XRef Type="Allelic variant" ID="167409.0005" DB="OMIM" />
                <XRef Type="Allelic variant" ID="167409.0010" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">RENAL-COLOBOMA SYNDROME WITH MACULAR ABNORMALITIES</ElementValue>
                <XRef Type="MIM" ID="120330" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Papillorenal syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">CONGENITAL ANOMALIES OF THE KIDNEY AND URINARY TRACT WITH OR WITHOUT OCULAR ABNORMALITIES</ElementValue>
                <XRef Type="MIM" ID="120330" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">CAKUT WITH OR WITHOUT OCULAR ABNORMALITIES</ElementValue>
                <XRef Type="MIM" ID="120330" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">PAPRS</ElementValue>
                <XRef Type="MIM" ID="120330" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="4106" />
                <XRef ID="4106" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">PAX2-related disorder is an autosomal dominant disorder associated with renal and eye abnormalities. The disorder was originally referred to as renal coloboma syndrome and characterized by renal hypodysplasia and abnormalities of the optic nerve; with improved access to molecular testing, a wider range of phenotypes has been recognized in association with pathogenic variants in PAX2. Abnormal renal structure or function is noted in 92% of affected individuals and ophthalmologic abnormalities in 77% of affected individuals. Renal abnormalities can be clinically silent in rare individuals. In most individuals, clinically significant renal insufficiency / renal failure is reported. End-stage renal disease requiring renal transplant is not uncommon. Uric acid nephrolithiasis has been reported. Ophthalmologic abnormalities are typically described as optic nerve coloboma or dysplasia. Iris colobomas have not been reported in any individual with PAX2–related disorder. Ophthalmologic abnormalities may significantly impair vision in some individuals, while others have subtle changes only noted after detailed ophthalmologic examination. Additional clinical findings include high-frequency sensorineural hearing loss, soft skin, and ligamentous laxity. PAX2 pathogenic variants have been identified in multiple sporadic and familial cases of nonsyndromic renal disease including renal hypodysplasia and focal segmental glomerulosclerosis.</Attribute>
                <XRef ID="NBK1451" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301624</ID>
                <ID Source="BookShelf">NBK1451</ID>
              </Citation>
              <Citation Type="Translational/Evidence-based" Abbrev="EuroGenetest, 2011">
                <ID Source="PubMed">21326282</ID>
              </Citation>
              <XRef ID="1475" DB="Orphanet" />
              <XRef ID="C1852759" DB="MedGen" />
              <XRef ID="MONDO:0007352" DB="MONDO" />
              <XRef Type="MIM" ID="120330" DB="OMIM" />
            </Trait>
            <Trait ID="31865" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Focal segmental glomerulosclerosis 7</ElementValue>
                <XRef ID="MONDO:0014451" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">FSGS7</ElementValue>
                <XRef Type="MIM" ID="616002" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="16045" />
                <XRef ID="16045" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="656" DB="Orphanet" />
              <XRef ID="C4014925" DB="MedGen" />
              <XRef ID="MONDO:0014451" DB="MONDO" />
              <XRef Type="MIM" ID="616002" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="6041424" SubmissionDate="2024-02-15" DateLastUpdated="2024-02-28" DateCreated="2023-02-07">
        <ClinVarSubmissionID localKey="16486281|MedGen:C1852759;C4014925" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003349966" DateUpdated="2024-02-28" DateCreated="2023-02-07" Type="SCV" Version="2" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-04-24">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">11461952</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">24676634</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Gly81Valfs*2) in the PAX2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in PAX2 are known to be pathogenic (PMID: 11461952, 24676634). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with PAX2-related conditions. For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PAX2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000010.10:g.102510478del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease" multipleConditionExplanation="Uncertain">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1852759" Type="CUI" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C4014925" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12507860</SubmissionName>
          <SubmissionName>SUB14224806</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="6041424" TraitType="Disease" MappingType="XRef" MappingValue="C4014925" MappingRef="MedGen">
        <MedGen CUI="C4014925" Name="Focal segmental glomerulosclerosis 7" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="6041424" TraitType="Disease" MappingType="XRef" MappingValue="C1852759" MappingRef="MedGen">
        <MedGen CUI="C1852759" Name="Renal coloboma syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

